SeaSpine Corporation (SPNE)
Company Description
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally.
It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine.
The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures.
It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM.
In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine.
SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.

Country | United States |
IPO Date | Jun 17, 2015 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 523 |
CEO | Keith C. Valentine |
Contact Details
Address: 5770 Armada Drive Carlsbad, California United States | |
Website | https://www.seaspine.com |
Stock Details
Ticker Symbol | SPNE |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001637761 |
CUSIP Number | 81255T108 |
ISIN Number | US81255T1088 |
Employer ID | 47-3251758 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Keith C. Valentine | Pres, Chief Executive Officer & Director |
John J. Bostjancic | Senior Vice President, Chief Financial Officer, Chief Operating Officer & Treasurer |
Carrie Mendivil | Head of Investor Relations |
Dennis L. Cirino | Senior Vice President of Global Spinal Systems |
Dr. Beau Standish P.Eng., Ph.D. | Pres of Enabling Technologies |
Dr. Frank Vizesi | Chief Scientific Officer |
Hollis Winkler | Senior Vice President of HR |
John J. Winge | Vice President of Sales |
Patrick L. Keran J.D. | Senior Vice President, Gen. Counsel & Sec. |
Tyler P. Lipschultz | Senior Vice President of Orthobiologics & Bus. Devel. |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 03, 2023 | CT ORDER | Filing |
Jan 31, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Jan 17, 2023 | 15-12G | Filing |
Jan 09, 2023 | 4 | Filing |
Jan 09, 2023 | 4 | Filing |
Jan 09, 2023 | 4 | Filing |
Jan 09, 2023 | 4 | Filing |
Jan 09, 2023 | 4 | Filing |
Jan 09, 2023 | 4 | Filing |
Jan 09, 2023 | 4 | Filing |